<i>SPDL1</i> inhibition enhances colorectal cancer progression <i>via</i> epidermal growth factor receptor/extracellular signal-regulated kinase pathways
This study showed that the loss of SPDL1 may induce EMT and promote cell migration and invasion in CRC through the EGFR/ERK pathway.
Authors
- Peng Peng (ORCID: https://orcid.org/0000-0001-8648-1703)
- Jiean Huang (ORCID: https://orcid.org/0000-0003-0431-1888)
- Mengbin Qin (ORCID: https://orcid.org/0000-0001-9927-5482)
- Juan Sun
- Mengshi Li (ORCID: https://orcid.org/0000-0003-3398-0183)
- Jinxiu Zhang (ORCID: https://orcid.org/0000-0003-1422-6126)
- Shiquan Liu (ORCID: https://orcid.org/0000-0002-3552-8732)
- Ruo-Xi Cheng
Institutions
- Guangxi Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.4251/wjgo.v17.i5.104686
- Citations
- 2
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.87